| James T Power Iii, MD | |
|
280 Homeolu Place, Kaunakakai, HI 96748-0408 | |
| (808) 553-3141 | |
| (808) 553-3140 |
| Full Name | James T Power Iii |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 280 Homeolu Place, Kaunakakai, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164409546 | NPI | - | NPPES |
| 51864901 | Medicaid | HI | |
| 121813 | Other | MEDICARE FQHC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD6345 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James T Power Iii, MD Po Box 682, Kapaau, HI 96755-0682 Ph: (808) 884-5190 | James T Power Iii, MD 280 Homeolu Place, Kaunakakai, HI 96748-0408 Ph: (808) 553-3141 |
News Archive
Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely to have their cancer recur or spread.
As concerns mount over whether there will be enough physicians to meet the nation's growing demand for health care, the number of osteopathic physicians (DOs) is reaching new heights, according to a report released today from the American Osteopathic Association.
The regulation focuses on state exchanges and requires that these marketplaces report information such as enrollees' names, addresses, birthdates and premium amounts. In addition, news outlets also examine what went wrong in states with problem-plagued websites and what is happening in locations where the marketplaces have proven popular.
Breast cancer patients may be at an increased risk of cardiovascular diseases including heart failure and may benefit from a treatment approach that weighs the benefits of specific therapies against potential damage to the heart, according to a new scientific statement from the American Heart Association published in its journal Circulation.
Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year follow-up evaluations, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
› Verified 8 days ago
Donald C. Fancher, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 280 Homeolu Place, Kaunakakai, HI 96748 Phone: 808-553-5331 Fax: 808-553-3133 | |
Barbara Kelly, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 280 Home Olu Street, Kaunakakai, HI 96748 Phone: 808-553-3123 |